Episode Details

Back to Episodes
Novo Nordisk In Trouble For Not Reporting Serious Adverse Events to the FDA

Novo Nordisk In Trouble For Not Reporting Serious Adverse Events to the FDA

Published 3 months, 1 week ago
Description

Remember when I wrote about the FDA Averse Events Reporting System and how the drug companies are required to report adverse events? Novo Nordisk just got a warning from the FDA for…not doing that.



Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us